Cigna Coverage Policy Update for ClariFix® Cryotherapy, Enhancing Patient Access for Chronic Rhinitis Treatment

Portage, Michigan, USA – July 7, 2025 – Stryker, a global leader in medical technologies,today announced that Cigna Healthcare will reclassify ClariFix® (CPT® 31243), removing it from the insurer’s experimental, investigational, and unproven procedures list, e􀆯ffective September 15, 2025. This policy update marks a significant advancement in patient access to an evidence-based treatment for chronic rhinitis.

ClariFix is a minimally invasive solution that targets the underlying cause of chronic rhinitis, a persistent and inflammatory condition known to severely impact quality of life.“We are extremely pleased with Cigna’s decision, which a􀆯ims ClariFix as a treatment for individuals su􀆯ffering from chronic rhinitis,” said Mitch Foley, vice president and general manager, Stryker's ENT business. “Broadening patient access to this treatment reflects a meaningful shift in the standard of care. We sincerely thank Dr. Rahul Shah and the American Academyof Otolaryngology–Head and Neck Surgery for their advocacy and commitment to patient access.”

ClariFix delivers targeted cryotherapy using a proprietary, flexible device designed to disrupt the posterior nasal nerve—helping alleviate the excessive mucus production and congestion associated with chronic rhinitis. The procedure is performed in-off􀆯ice under local anesthesia, requires no incisions, and typically involves minimal recovery time. To review the full details of Cigna’s updated medical policy, click here. 

Although CPT® 31243 has been removed from Cigna’s investigational list, healthcare providers are advised to continue monitoring relevant policy changes. Stryker does not guarantee coverage, reimbursement, or payment levels for ClariFix or services associated with its use. It remains the responsibility of the provider to determine medical necessity, accurately document clinical information, and appropriately report diagnostic codes,services provided, and applicable billing modifiers.

See additional reimbursement resources. 

Learn more about ClariFix. 

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We off􀆯er innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.CPT Copyright 2024 American Medical Association. All rights reserved. CPT is a registeredtrademark of the American Medical Association.